Reuters -- Valeant Pharmaceuticals International posted a better-than-expected quarterly profit, helped partly by higher revenue from its specialty pharmaceutical segment, and raised its 2009 earnings view.
Reuters -- Valeant Pharmaceuticals International posted a better-than-expected quarterly profit, helped partly by higher revenue from its specialty pharmaceutical segment, and raised its 2009 earnings view.
